Cellular and humoral immunogenicity of the COVID-19 vaccine and COVID-19 disease severity in individuals with immunodeficiency

BACKGROUND: A well-coordinated adaptive immune response is crucial for limiting COVID-19 disease. Some individuals with immunodeficiency are at a high risk of developing severe COVID-19. Therefore, the development of standardized methods for measuring different arms of the vaccine response in the se...

Descripción completa

Detalles Bibliográficos
Autores principales: Murray, C. E., O’Brien, C., Alamin, S., Phelan, S. H., Argue, R., Kiersey, R., Gardiner, M., Naughton, A., Keogh, E., Holmes, P., Naughton, S., Scanlon, A., Sloan, A., McCrea, P., Sui, J., Dunne, J., Conlon, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080028/
https://www.ncbi.nlm.nih.gov/pubmed/37033955
http://dx.doi.org/10.3389/fimmu.2023.1131604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080028/
https://www.ncbi.nlm.nih.gov/pubmed/37033955
http://dx.doi.org/10.3389/fimmu.2023.1131604

Ejemplares similares